City Therapeutics, Inc. Common Stock Financial Flexibility Index
City Therapeutics, Inc. Common Stock financial flexibility index. City Therapeutics, Inc. Common Stock (CTY) has a Financial Flexibility Index of 0.11x as of June 2020. Free cash flow of $988.00 Million (operating CF $699.00 Million minus capex $289.00 Million) represents 0% of total liabilities ($9.32 Billion). See CTY free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of City Therapeutics, Inc. Common Stock (2005–2025)
Financial flexibility index of City Therapeutics, Inc. Common Stock from 2005 to 2025. Historical Financial Flexibility Index trend for City Therapeutics, Inc. Common Stock across 17 annual periods. Check earnings quality score of City Therapeutics, Inc. Common Stock to evaluate the quality of earnings relative to operating cash generation.
City Therapeutics, Inc. Common Stock Financial Flexibility Index by Year (2005–2025)
City Therapeutics, Inc. Common Stock financial flexibility index by year from 2005 to 2025. Year-by-year free cash flow to debt coverage for City Therapeutics, Inc. Common Stock. For the full cash flow conversion analysis, see CTY operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.17x | $-39.21 Million | $-41.61 Million | $234.42 Million | ▼ -73.4% |
| 2024 | -0.10x | $-16.85 Million | $-20.39 Million | $174.78 Million | ▼ -123.9% |
| 2019 | 0.40x | $4.39 Billion | $3.33 Billion | $10.88 Billion | ▼ -10.6% |
| 2018 | 0.45x | $4.83 Billion | $3.79 Billion | $10.71 Billion | ▲ +38.2% |
| 2017 | 0.33x | $3.76 Billion | $2.44 Billion | $11.53 Billion | ▲ +3.9% |
| 2016 | 0.31x | $3.91 Billion | $2.65 Billion | $12.46 Billion | ▲ +2.8% |
| 2015 | 0.31x | $3.84 Billion | $2.59 Billion | $12.56 Billion | ▲ +2.2% |
| 2014 | 0.30x | $3.97 Billion | $2.80 Billion | $13.27 Billion | ▲ +2.2% |
| 2013 | 0.29x | $3.98 Billion | $2.71 Billion | $13.61 Billion | ▲ +1.1% |
| 2012 | 0.29x | $4.04 Billion | $2.77 Billion | $13.97 Billion | ▲ +34.4% |
| 2011 | 0.22x | $3.24 Billion | $2.20 Billion | $15.04 Billion | ▼ -30.2% |
| 2010 | 0.31x | $4.47 Billion | $3.23 Billion | $14.52 Billion | ▲ +6.2% |
| 2009 | 0.29x | $4.27 Billion | $3.17 Billion | $14.73 Billion | ▼ -12.9% |
| 2008 | 0.33x | $4.88 Billion | $3.48 Billion | $14.66 Billion | ▲ +11.8% |
| 2007 | 0.30x | $4.30 Billion | $3.26 Billion | $14.42 Billion | ▲ +1.7% |
| 2006 | 0.29x | $4.32 Billion | $3.13 Billion | $14.74 Billion | ▼ -3.9% |
| 2005 | 0.31x | $4.65 Billion | $3.42 Billion | $15.23 Billion | — |